Monte Rosa Therapeutics, Inc. (GLUE)
10.31
-0.01
(-0.10%)
USD |
NASDAQ |
Oct 09, 16:00
10.30
-0.01
(-0.10%)
After-Hours: 20:00
Monte Rosa Therapeutics Market Cap : 878.68M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 879.54M |
| October 07, 2026 | 866.75M |
| October 06, 2026 | 841.18M |
| October 05, 2026 | 875.28M |
| October 02, 2026 | 894.88M |
| October 01, 2026 | 959.65M |
| September 30, 2026 | 1.017B |
| September 29, 2026 | 1.001B |
| September 28, 2026 | 998.00M |
| September 25, 2026 | 1.003B |
| September 24, 2026 | 998.85M |
| September 23, 2026 | 1.013B |
| September 22, 2026 | 1.074B |
| September 21, 2026 | 1.045B |
| September 18, 2026 | 1.034B |
| September 17, 2026 | 1.074B |
| September 16, 2026 | 1.078B |
| September 15, 2026 | 1.107B |
| September 14, 2026 | 1.185B |
| September 11, 2026 | 1.199B |
| September 10, 2026 | 1.220B |
| September 09, 2026 | 1.215B |
| September 08, 2026 | 1.216B |
| September 04, 2026 | 1.180B |
| September 03, 2026 | 1.226B |
| Date | Value |
|---|---|
| September 02, 2026 | 1.212B |
| September 01, 2026 | 1.220B |
| August 31, 2026 | 1.188B |
| August 28, 2026 | 1.140B |
| August 27, 2026 | 1.220B |
| August 26, 2026 | 1.226B |
| August 25, 2026 | 1.241B |
| August 24, 2026 | 1.174B |
| August 21, 2026 | 1.219B |
| August 20, 2026 | 1.260B |
| August 19, 2026 | 1.344B |
| August 18, 2026 | 1.281B |
| August 17, 2026 | 1.311B |
| August 14, 2026 | 1.321B |
| August 13, 2026 | 1.350B |
| August 12, 2026 | 1.359B |
| August 11, 2026 | 1.343B |
| August 10, 2026 | 1.348B |
| August 07, 2026 | 1.353B |
| August 06, 2026 | 1.339B |
| August 05, 2026 | 1.330B |
| August 04, 2026 | 1.370B |
| August 03, 2026 | 1.297B |
| July 31, 2026 | 1.393B |
| July 30, 2026 | 1.912B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| United Therapeutics Corp. | 23.44B |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.10B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.012B |
Market Cap Related Metrics
| PS Ratio | 31.34 |
| Price to Book Value | 1.803 |
| Price | 10.31 |
| Earnings Yield | -18.49% |